Development of macrolide resistance in Bordetella bronchiseptica is associated with the loss of virulence
Author(s) -
Kalyan K. Dewan,
Amanda L. Skarlupka,
Israel Rivera,
Laura E. Cuff,
Mónica Cartelle Gestal,
Dawn L. Taylor-Mulneix,
Shan M. Wagner,
Valerie E. Ryman,
Coralis Rodríguez,
Illiassou Hamidou Soumana,
Bruce R. Levin,
Eric T. Harvill
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky264
Subject(s) - bordetella bronchiseptica , microbiology and biotechnology , biology , virulence , streptococcus pneumoniae , antibiotics , bordetella , erythromycin , antibiotic resistance , bacteria , drug resistance , gene , bordetella pertussis , genetics
Why resistance to specific antibiotics emerges and spreads rapidly in some bacteria confronting these drugs but not others remains a mystery. Resistance to erythromycin in the respiratory pathogens Staphylococcus aureus and Streptococcus pneumoniae emerged rapidly and increased problematically. However, resistance is uncommon amongst the classic Bordetella species despite infections being treated with this macrolide for decades.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom